Invesaro

Stocks COLD Financial statements

Financial statements

AMERICOLD REALTY TRUST financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMERICOLD REALTY TRUST files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,4901,5441,6041,7841,9882,7152,9152,6732,6672,602
Cost of revenue2,2191,9031,8201,762
Gross profit696771847839
Selling, general and administrative96.799.6111129145182231227255269
Operating income1321371801311687387.9-1081247.23
Interest expense12011593.394.491.599.2116140135148
Interest income0.711.0746.291.160.841.63
Other non-operating income-1.37-1.94-0.53-1.87-2.562.022.462.827.96.92
Pre-tax income10.88.7944.44317.6-30.6-29.9-328-103-136
Income tax5.889.39-3.62-5.16-6.93-1.57-18.8-2.27-8.43-20.5
Income from continuing operations-29-11.1-326-94.7-115
Net income to minority interests000.020.15-0.03-0.05-0.44-0.73
Net income4.93-0.614848.224.5-30.5-19.4-336-94.3-115
EBITDA251254298295384393419245485375
EPS, basic-0.35-0.430.310.260.11-0.12-0.07-1.22-0.33-0.40
EPS, diluted-0.35-0.430.310.260.11-0.12-0.07-1.22-0.33-0.40
Shares, basic (weighted)69.970141180203259270276285286
Shares, diluted (weighted)69.970144184207259270276285286
Dividend per share0.290.290.740.82

Balance sheet

FY2016FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents22.848.92082346218353.160.447.7137
Inventory10.47.889.3721.52729.37.247.436.83
Property, plant and equipment1,8351,8402,9334,7675,1285,0665,1075,0215,345
Lease right-of-use assets059.6267320276247222180
Goodwill1871881863187941,0731,034794784828
Intangible assets26.625.1285797981925897839819
Total assets2,3952,5324,1717,8318,2168,1057,8697,7368,122
Total liabilities2,2091,8262,3384,0384,1874,3174,2354,4295,200
Total debt2,648
Paid-in capital3941,3562,5824,6885,1725,1925,6265,6475,664
Retained earnings-581-638-737-896-1,158-1,415-1,996-2,342-2,719
Other comprehensive income-0.23-12.5-14.1-4.384.52-6.05-16.6-27.3-63.2
Shareholders' equity-149-1877071,8333,7904,0213,7733,6163,2812,884
Minority interests02.388.0714.518.526.237.6
Total equity-149-1877071,8333,7934,0293,7883,6353,3072,922
Total liabilities and equity2,3952,5324,1717,8318,2168,1057,8697,7368,122
Shares outstanding69.4148192252268270284284285

Cash flow statement

FY2016FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income4.93-0.614848.224.6-30.3-19.5-336-94.7-115
Depreciation and amortization119117118163216320331354361367
Stock-based compensation2.52.410.715.917.923.927.123.628.230.2
Deferred income tax-0.59-3.66-3.15-10.7-13.7-9.15-22.6-10.8-13.2-26.6
Change in receivables-19.11.6-1.94-3.68-12.9-60.5-68.6-2.7522.720.9
Change in payables-4.5718.2-5.220.8419.5-7.513.323.517.3-17
Cash from operations119163188236294273300366412360
Capital expenditures-74.9-149-145-217-377-438-308-264-309-577
Acquisitions00-1,320-1,859-741-15.8-46.70-108
Cash from investing-41.7-139-126-1,605-2,249-1,239-348-357-313-658
Debt issued0060035092200
Stock issued005861,2071,579474041300
Dividends paid-20.2-20.2-76.5-135-167-228-239-242-252-261
Cash from financing-95.3-18.684.91,3952,33043123.3-0.29-107383
Exchange rate effect-0.281.14-3.28-0.115.98-3.44-4.73-1.47-4.654.32
Net change in cash-18.25.8914726.6374-535-25.28.8-8.0984.9
Free cash flow43.914.34319-83.1-165-8.37102102-217
Interest paid11510785.66882.887.7118135122138
Income taxes paid10.911.95.512.211.4910.87.895.836.725.85

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $14.74 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin31.7%Gross profit / revenue.
Operating margin-12.5%Operating income / revenue.
EBITDA margin2.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-18.0%Pre-tax income / revenue.
Net margin-17.4%Net income / revenue.
FCF margin-7.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin13.4%Cash from operations / revenue.
Return on equity (ROE)-18.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-5.8%Net income / average total assets.
Return on invested capital (ROIC)-10.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue10.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue20.5%Capital expenditures / revenue.
D&A / revenue14.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-2.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-3.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-0.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y6.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y-94.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-56.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y-46.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-22.7%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-3.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-0.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-12.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y6.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y4.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-312.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-12.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-8.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-5.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y5.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y0.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y0.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y6.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Liabilities / assets68.6%Total liabilities / total assets.
Interest coverage-2.07xOperating income / interest expense.
Goodwill and intangibles / assets20.8%(Goodwill + intangible assets) / total assets.
Tangible book value$790.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.33xRevenue / average total assets.
Fixed asset turnover0.51xRevenue / average property, plant and equipment.
Capex / operating cash flow153.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.59Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$9.11Revenue / diluted weighted shares.
FCF per share-$0.66Free cash flow / diluted weighted shares.
Operating cash flow per share$1.22Cash from operations / diluted weighted shares.
Book value per share$8.46Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.77Tangible book value / shares outstanding.
Cash per share$0.14(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$4.21BShare price x shares outstanding.
Enterprise value$4.17BMarket cap + total debt - cash - short-term investments.
P/S1.61xMarket cap / revenue.
P/B1.74xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book5.32xMarket cap / tangible book value, when positive.
P/OCF12.1xMarket cap / cash from operations, when positive.
EV/Sales1.59xEnterprise value / revenue.
EV/EBITDA73.9xEnterprise value / EBITDA, when both are positive.
FCF yield-4.5%Free cash flow / market cap.
Earnings yield-10.8%Net income / market cap (the inverse of P/E).
Dividend yield6.3%Dividends paid over the period / market cap.
Shareholder yield6.3%(Dividends paid + share buybacks) / market cap.
What was AMERICOLD REALTY TRUST's revenue in fiscal 2025?

AMERICOLD REALTY TRUST reported revenue of $2.60B for fiscal 2025, 2.4% lower than the year before.

Was AMERICOLD REALTY TRUST profitable in fiscal 2025?

No. It reported a net loss of $114.5M.

How much free cash flow did AMERICOLD REALTY TRUST generate in fiscal 2025?

Cash from operations of $359.6M minus capital expenditures of $576.8M left free cash flow of -$217.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AMERICOLD REALTY TRUST